Pfizer vaccine for kids under 5: FDA authorization paused for data
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.
Stay updated with breaking news from Their Future. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.